Skip to main navigation Skip to main content
  • KSCN
  • E-Submission

CNR : Clinical Nutrition Research

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

2
results for

"Alanine aminotransferase"

Article category

Keywords

Publication year

Authors

"Alanine aminotransferase"

Original Articles
[English]
Effects of Artichoke Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mohammad Reza Amini, Fatemeh Sheikhhossein, Alireza Talebyan, Elham Bazshahi, Farhang Djafari, Azita Hekmatdoost
Clin Nutr Res 2022;11(3):228-239.   Published online July 25, 2022
DOI: https://doi.org/10.7762/cnr.2022.11.3.228

Studies examining the effect of artichoke on liver enzymes have reported inconsistent results. This systematic review and meta-analysis aimed to assess the effects of artichoke administration on the liver enzymes. PubMed, Embase, the Cochrane Library, and Scopus databases were searched for articles published up to January 2022. Standardized mean difference (Hedges’ g) were analyzed using a random-effects model. Heterogeneity, publication bias, and sensitivity analysis were assessed for the liver enzymes. Pooled analysis of seven randomized controlled trials (RCTs) suggested that the artichoke administration has an effect on both alanine aminotransferase (ALT) (Hedges’ g, −1.08; 95% confidence interval [CI], −1.76 to −0.40; p = 0.002), and aspartate aminotransferase (AST) (Hedges’ g, −1.02; 95% CI, −1.76 to −0.28; p = 0.007). Greater effects on ALT were detected in trials that lasted ≤8 weeks. Also, greater effects on AST were detected in trials using > 500 mg artichoke. Overall, this meta-analysis demonstrated artichoke supplementation decreased ALT and AST.

Citations

Citations to this article as recorded by  
  • Artichoke and cardiometabolic health: A systematic and meta-analytic synthesis of current evidence
    Ali Jafari, Mohammad Amin Karimi, Mahsa Mahmoudinezhad, Fatemeh Razavi, Helia Mardani, Vali Musazadeh
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2025; 19(10): 103328.     CrossRef
  • The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis
    Shubham Sharma, Anjali Sharma, Parul Gupta, Deepshi Arora, Geeta Deswal, Ajmer Grewal, Devkant Sharma
    Cardiovascular & Hematological Disorders-Drug Targets.2025; 25(3): 168.     CrossRef
  • Artichoke leaf extract reduces steatosis and decreases liver size in prebariatric patients: A randomized placebo-controlled pilot trial—The “SteatoChoke-Study”
    Sebastian Holländer, Evelyn Marth, Philipp Robert Scherber, Antonios Spiliotis, Ammar Al-Ali, Gereon Gäbelein, Matthias Glanemann
    Journal of Clinical Lipidology.2025;[Epub]     CrossRef
  • Relato de Caso: Alergias e Intolerâncias Alimentares na Prática de Consultório
    Karla Raissa Ferreira de Carvalho, Niraldo Paulino, Gabriela Cicalise de Souza Santos, Joycelene Ribeiro Viana Movilha, Vanessa Carolina Costa Amaral, Amanda Magalhães das Neves, Érica da Silva Romão Cassiano
    Revista de Gestão e Secretariado.2025; 16(10): e5300.     CrossRef
  • In‐depth assessment of steatotic liver disease awareness in high‐risk groups
    Murat Özdede, Alper Tuna Güven, Burcu Çelik Eroğlu
    Journal of Evaluation in Clinical Practice.2025;[Epub]     CrossRef
  • An Overview of the Versatility of the Parts of the Globe Artichoke (Cynara scolymus L.), Its By-Products and Dietary Supplements
    Beata Olas
    Nutrients.2024; 16(5): 599.     CrossRef
  • Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review
    Pablo Ayuso, Jhazmin Quizhpe, María de los Ángeles Rosell, Rocío Peñalver, Gema Nieto
    Applied Sciences.2024; 14(11): 4940.     CrossRef
  • Functional and Therapeutic Potential of Cynara scolymus in Health Benefits
    Chiara Porro, Tarek Benameur, Antonia Cianciulli, Mirco Vacca, Margherita Chiarini, Maria De Angelis, Maria Antonietta Panaro
    Nutrients.2024; 16(6): 872.     CrossRef
  • Medicinal Plant-derived Phytochemicals in Detoxification
    Geir Bjørklund, Natália Cruz-Martins, Bey Hing Goh, Olha Mykhailenko, Roman Lysiuk, Mariia Shanaida, Larysa Lenchyk, Taras Upyr, Marius Emil Rusu, Antonina Pryshlyak, Volodymyr Shanaida, Salvatore Chirumbolo
    Current Pharmaceutical Design.2024; 30(13): 988.     CrossRef
  • From Scraps to Solutions: Harnessing the Potential of Vegetable and Fruit Waste in Pharmaceutical Formulations
    Vishnu Mittal, Anjali Sharma
    Letters in Functional Foods.2024;[Epub]     CrossRef
  • 15 View
  • 0 Download
  • 10 Crossref
[English]
The Effects of Nigella sativa Supplementation on Liver Enzymes Levels: a Systematic Review and Meta-analysis of Randomized Controlled Trials
Neda Azizi, Mohammad Reza Amini, Kurosh Djafarian, Sakineh Shab-Bidar
Clin Nutr Res 2021;10(1):72-82.   Published online January 29, 2021
DOI: https://doi.org/10.7762/cnr.2021.10.1.72

The present systematic review and meta-analysis aimed to investigate the effects of Nigella sativa (N. sativa) supplementation on liver enzymes levels including aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Relevant studies, published from inception up to January 2020, were searched through PubMed, Scopus and Google Scholar conducted on randomized controlled trials (RCTs) investigating the effect of N. sativa on serum AST and ALT levels. Meta-analysis was applied using a random-effects model. Eight studies met inclusion criteria (n=281 in the N. sativa and n = 279 in placebo group). This meta-analysis showed that N. sativa supplementation significantly reduced AST level (weighted mean difference [WMD], −8.11 IU/L; 95% confidence interval [CI], −13.6, −2.53; p = 0.004) with significant heterogeneity (I-squared, 95.9%; p < 0.001) while the decrease in ALT level was not statistically significant (WMD, −7.26 IU/L; 95% CI, −15.4, 0.04; p = 0.051) with significant heterogeneity (I-squared, 97.8%; p < 0.001). This meta-analysis suggests that N. sativa supplementation may improve AST levels and ALT levels, however more RCTs with larger sample size are needed to found effects of N. sativa on liver enzymes in patients with non-alcoholic fatty liver disease.

Citations

Citations to this article as recorded by  
  • Clinical and In vitro Data Shed New Light on the Therapeutic Advantages of Black Seeds (Nigella sativa) for the Treatment of Hepatitis C and Hepatitis B Viral Infections
    Naina Mohamed Pakkir Maideen, Rajkapoor balasubramanian, Kumar Balasubramanian, Mohamed Harsath Jahir Hussain, Mohamed Fahath Shahul Hameed, Rethesh Senthil
    Infectious Disorders - Drug Targets.2025;[Epub]     CrossRef
  • The effect of plant growth regulators, FeO3-CTs nanoparticles and LEDs light on the growth and biochemical compounds of black seed (Nigella sativa L.) callus in vitro
    Ali Sobhannizadeh, Mousa Torabi Giglou, Mahdi Behnamian, Asghar Estaji, Mohammad Majdi, Antoni Szumny
    BMC Plant Biology.2025;[Epub]     CrossRef
  • Effects of black seed (Nigella sativa L.) on cardiometabolic indices in type 2 diabetic patients: A systematic review and meta-analysis of RCTs
    Mehdi Karimi, Samira Pirzad, Seyed Morteza Ali Pourfaraji, Fatemeh Maleki Sedgi, Bahar Darouei, Reza Amani-Beni, Kimia Kazemi, Reyhaneh Rabiee
    Complementary Therapies in Medicine.2025; 90: 103174.     CrossRef
  • The protective effect of various forms of Nigella sativa against hepatorenal dysfunction: underlying mechanisms comprise antioxidation, anti- inflammation, and anti-apoptosis
    Reham M. Algheshairy, Hend F. Alharbi, Mona S. Almujaydil, Raghad M. Alhomaid, Hoda A. Ali
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Does Nigella sativa supplementation improve cardiovascular disease risk factors? A comprehensive GRADE-assessed systematic review and dose-response meta-analysis of 82 randomized controlled trials
    Ali Jafari, Helia Mardani, Amir Hossein Faghfouri, Zahra Mirzaei Fashtali, Mohtaram Hashemi, Matin Abdollahi Yousefabady, Reihane Javid, Sahar Golabi, Bahareh Arghavan, Vali Musazadeh, Mahshid Naghashpour
    Pharmacological Research.2025; 219: 107882.     CrossRef
  • Polycystic ovary syndrome and its management: In view of oxidative stress
    Koushik Bhattacharya, Rajen Dey, Debanjana Sen, Nimisha Paul, Asim Kumar Basak, Mohuya Patra Purkait, Nandini Shukla, Gargi Ray Chaudhuri, Aniruddha Bhattacharya, Rajkumar Maiti, Krishnendu Adhikary, Prity Chatterjee, Prithviraj Karak, Alak Kumar Syamal
    Biomolecular Concepts.2024;[Epub]     CrossRef
  • Immune stimulatory effect of Nigella sativa in healthy animal models: A systematic review and meta-analysis
    Abdulsamad Alsalahi, Nian N.N. Maarof, Mohammed A. Alshawsh, Musheer A. Aljaberi, Mousa A. Qasem, Abdulaleem Mahuob, Nassrin A. Badroon, Ebthag A.M. Mussa, Rukman A. Hamat, Atiyah M. Abdallah
    Heliyon.2024; 10(6): e27390.     CrossRef
  • Nigella sativa and health outcomes: An overview of systematic reviews and meta-analyses
    Zhongyu Li, Yang Wang, Qing Xu, Jinxin Ma, Xuan Li, Jiaxing Yan, Yibing Tian, Yandong Wen, Ting Chen
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Effect of Nigella sativa on Selected Gastrointestinal Diseases
    Sara Jarmakiewicz-Czaja, Magdalena Zielińska, Kacper Helma, Aneta Sokal, Rafał Filip
    Current Issues in Molecular Biology.2023; 45(4): 3016.     CrossRef
  • Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
    Małgorzata Szczuko, Justyna Kikut, Urszula Szczuko, Iwona Szydłowska, Jolanta Nawrocka-Rutkowska, Maciej Ziętek, Donatella Verbanac, Luciano Saso
    Nutrients.2021; 13(7): 2452.     CrossRef
  • The effect of nanomicelle curcumin supplementation and Nigella sativa oil on the expression level of miRNA‐21, miRNA‐422a, and miRNA‐503 gene in postmenopausal women with low bone mass density: A randomized, triple‐blind, placebo‐controlled clinical trial
    Azizeh Farshbaf‐Khalili, Safar Farajnia, Samira Pourzeinali, Seyed Kazem Shakouri, Hanieh Salehi‐Pourmehr
    Phytotherapy Research.2021; 35(11): 6216.     CrossRef
  • 24 View
  • 0 Download
  • 11 Crossref